Assess whether to quote, refer, or decline from D&O claims-made notice
August 31, 2026
SITUATION D&O claims-made notice and prior-acts history arrived with a product that just got an FDA warning letter for fleet auto renewal underwriter. That is a Insurance Underwriting Core Commercial Lines decision on to quote, refer, or decline in a cedent submitting a property treaty with thin bordereaux.
DECISION Fleet auto renewal underwriter in a cedent submitting a property treaty with thin bordereaux must choose To quote, refer, / Decline using D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter.
HYPOTHESES TO TEST 1. Fleet auto renewal underwriter can defend To quote, refer, from D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter in a Insurance Underwriting challenge. 2. Fleet auto renewal underwriter cannot defend To quote, refer, from D&O claims-made notice and prior-acts history; Decline is what the extract actually supports after a product that just got an FDA warning letter. 3. A product that just got an FDA warning letter never reached the population in D&O claims-made notice and prior-acts history — reopen intake, do not close to quote, refer, or decline. 4. Two facts in D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter conflict for fleet auto renewal underwriter; hold this Core Commercial Lines file.
ANALYSIS REQUIRED 1. Compare treaty versus facultative treatment for the risk to quote, refer, or decline names. 2. Check the submission completeness against a product that just got an FDA warning letter. 3. Say whether a cedent submitting a property treaty with thin bordereaux can bind, restrict, or decline from the file as it stands. 4. For this Insurance Underwriting Core Commercial Lines file, read D&O claims-made notice and prior-acts history against a product that just got an FDA warning letter and write the one fact that would move to quote, refer, or decline for fleet auto renewal underwriter.
RECOMMENDATION Choose To quote, refer, / Decline on this Insurance Underwriting / Core Commercial Lines packet (D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter). Lead with the Insurance Underwriting option D&O claims-made notice and prior-acts history can support after a product that just got an FDA warning letter, then the two facts that force it, then the Monday action for fleet auto renewal underwriter in a cedent submitting a property treaty with thin bordereaux.
COMMAND RETURNS - Bottom-line Insurance Underwriting option on to quote, refer, or decline, then the evidence in D&O claims-made notice and prior-acts history, then the action for fleet auto renewal underwriter - Hypothesis scorecard against D&O claims-made notice and prior-acts history: supported / rejected / untestable - Regulatory or exam hook Core Commercial Lines would cite - Core Commercial Lines finding in D&O claims-made notice and prior-acts history that a second reviewer can re-perform
Explore more
More Insurance Underwriting prompts
- Assess whether loss development requires a rate or a restriction (42d25c)
- Umbrella referral underwriter must resolve whether to quote, refer, or decline
- Fleet auto renewal underwriter must resolve whether loss development requires
- Assess whether pollution coverage should be site-specific or blanket (0bf864)
- Assess whether umbrella attachment is too thin for the hazard from fleet MVRs
Explore related decision areas
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

